Australia strikes deal for new Covid pill that could be used in treatment by early 2022

Molnupiravir has been shown to prevent serious illness and death, although it is still in late stage clinical trials

• Follow our Covid live blog for the latest updates
• Australia cases and data tracker;
• Get our free news app; get our morning email briefing

Australia has secured 300,000 courses of molnupiravir, an antiviral capsule to treat Covid-19 that could be in use by early 2022.

The Morrison government has struck a supply agreement with MSD to provide the oral treatment if it is approved by the Therapeutic Goods Administration.